Inventor · disambiguated record
Vesselina Cooke
Also filed as: COOKE VESSELINA
7 granted patents·4 pending applications·14 citations·filing 2014–2024
79Inventor score
Files withNOVARTIS AG11
Top patents by PatentIndex Score
11 records- 0190US11266653B2Combination therapyNOVARTIS AG·Filed 2018·Granted Mar 8, 2022·6 cites·13 claims
- 0289US10973829B2Therapeutic uses of a C-RAF inhibitorNOVARTIS AG·Filed 2017·Granted Apr 13, 2021·4 cites·12 claims
- 0387US12036227B2Combination therapyNOVARTIS AG·Filed 2022·Granted Jul 16, 2024·1 cites·14 claims
- 0485US12011449B2Therapeutic combinations comprising a c-RAF inhibitorNOVARTIS AG·Filed 2021·Granted Jun 18, 2024·1 cites·8 claims
- 0579US2025248996A1Protein kinase c inhibitors for treatment of uveal melanomaNOVARTIS AG·Filed 2024·Application pending·0 cites
- 0678US11413284B2Protein kinase C inhibitors for treatment of uveal melanomaNOVARTIS AG·Filed 2018·Granted Aug 16, 2022·2 cites·16 claims
- 0776US12208097B2Protein kinase C inhibitors for treatment of uveal melanomaNOVARTIS AG·Filed 2022·Granted Jan 28, 2025·0 cites·16 claims
- 0856US2023321110A1Combination therapy of a raf inhibitor and a mek inhibitor for the treatment of sarcomaNOVARTIS AG·Filed 2021·Application pending·0 cites
- 0954US2024000789A1Therapeutic combinations comprising a craf inhibitorNOVARTIS AG·Filed 2021·Application pending·0 cites
- 1047US10011874B2Androgen receptor mutationNOVARTIS AG·Filed 2014·Granted Jul 3, 2018·0 cites·2 claims
- 1144US2019175609A1Therapeutic uses of a c-raf inhibitorNOVARTIS AG·Filed 2017·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Vesselina Cooke files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →